News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Phaeton Research Appoints New Operations Director


10/19/2005 5:10:39 PM

Drug delivery problem-solver Phaeton Research (www.phaetonresearch.com), based in Nottingham, UK, has announced the appointment of Dr Shohré Nabahi as its new Operations Director. The company, re-launched during the Summer of 2003, is part of Prophilian Group, which also includes niche Phase I/IIa CRO Pharmaceutical Profiles (www.pharmprofiles.com), specialises in developing innovative solutions for difficult molecules via customised advanced drug delivery technologies. Shohré will be responsible for providing direction to Phaeton’s Pharmaceutical R&D group which is involved in developing products from concept to utilisation in Phase I clinical studies. She will also be promoting the involvement of Phaeton Research in developing future drug delivery technologies which will be appropriate for a range of global pharmaceutical and biotechnology companies with 'problem' molecules and would secure the company valuable Intellectual Property.

Read at WebitPR


comments powered by Disqus
WebitPR
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES